A new test which capitalises on existing knowledge and technology will increase diagnoses, speed up the process and save the NHS millions of pounds.
Academic rigor, journalistic flair
Articles on Hepatitis C
Displaying 1 - 20 of 45 articles
As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
A better understanding of CFS could lead to new treatments.
Somewhere along our evolutionary path, we lost the ability to defend against hepatitis C. But not all humans lost this ability.
July 28 is World Hepatitis Day, and with an effective cure for hepatitis C there is much to celebrate. But homelessness and the opioid epidemic are driving a surge in hepatitis infections.
To prevent the epidemic of liver cancer that looms on the horizon, we need to tackle hepatitis B, hepatitis C and obesity.
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Victoria should implement a new report's recommendation to allow peers to distribute clean injecting equipment, but it needs to go further to ensure safe drug use in prison.
If England eliminates hepatitis C, it will be the first country to do so. But how feasible is it?
HIV has no boundaries. Men and women in almost every country are affected. Yet strides have been made, so much so that many are able to think of living with AIDS rather than dying from it.
Maybe it's time the government listened to the advice offered by its Advisory Council on the Misuse of Drugs.
Gonorrhoea has seen a sharp increase in diagnosis rates, of up to 94% in some groups.
Hepatitis viruses are serious infections that damage the liver. There is an urgent need to deal with increased Hepatitis B infections in Kenya.
HIV, STIs and other dangerous infections are feeding off of the opioid epidemic, creating an even more complicated threat to public health.
NSW has changed its laws imposing criminal penalties on someone with an STI who doesn't take "reasonable precautions" to not infect their sexual partner.
Australia has been subsidising drugs to cure hepatitis C since March 2016. Unlike in many other countries, these are available to everyone with the disease and are much cheaper for our government.
Why is it only some viruses are transmissible by blood, and how does the virus actually move from person to person?
While other cancer rates fall or remain static, liver cancer is on the rise. Here's why we need to start paying attention.
The newer drugs for hepatitis C might mean fewer people are diagnosed with liver cancer.
A promising new immunotherapy to treat liver cancer has been discovered.
Top contributors
-
Professor of Medicine, Clinical Researcher and Epidemiologist, UNSW
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Adjunct Professor, Monash University; Associate Director and Head, Centre for Population Health, Burnet Institute
-
Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Associate Professor of Epidemiology & Program Head of Surveillance Evaluation and Research, UNSW
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Professor and Director of the Centre for Social Research in Health, UNSW
-
Associate professor, University of Technology Sydney
-
Senior Lecturer, La Trobe University
-
Professor and Executive Dean of School, Medical and Health Sciences, Edith Cowan University
-
Associate Professor and Head of the Surveillance and Evaluation Program for Public Health at the Kirby Institute, UNSW
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Senior Lecturer, School of Medical Sciences, Edith Cowan University
-
Professor of Health and Ethnicity, University of East London
-
Associate Professor in Law, Monash University
